Medtronic Inc. Chairman and CEO Omar Ishrak on Tuesday defended the data that his company submitted to federal regulators as part of the approval process for a bone-growth protein, saying they were sound and support the safe use of the spinal surgery product.
Medtronic said Tuesday its profit dropped 19 percent in the fourth-quarter and the device maker predicted lower-than-expected growth for the year ahead due to a continuing slump in sales of its implants.
Medtronic Inc., the world’s biggest medical device maker, said Wednesday that Omar Ishrak of GE Healthcare will become its new chairman and CEO in June.
Twenty Minnesota companies made it into the newest edition of Fortune 500, illustrating the state’s corporate strength.
Target Corp., Cargill Inc., General Mills Inc. and Medtronic Inc. are providing more than $13 million in grants to help support students in K-12 through 2014.
The outgoing chief executive of Medtronic told employees Monday he will continue to lead the medical device manufacturer as its board of directors continues the search for a replacement.
A federal judge in Delaware has ruled that certain heart pacemakers sold by Medtronic Inc. do not infringe patents claimed by rival medical device manufacturer Boston Scientific Corp.
Medtronic, the world’s largest medical device maker, said Tuesday it will lay off up to 2,000 workers as part of a restructuring effort to make up for anemic sales of its implants.
Millions of people walk around with a potential time bomb inside and most do not know it. Medtronic now has a new device on the market to fight the so-called Silent Killer, Abdominal Aortic Aneurysm or AAA.
As Valentine’s Day approaches it may be good to have your heart all aflutter. But, for up to three million Americans, it is a daily occurrence and that is not a good thing.
Twin Cities-based Medtronic has received government approval for the first heart pacemaker designed to be safely used with MRI scanners.
Medtronic said Monday that Chairman and CEO William A. Hawkins will step down in April after three years leading the world’s largest medical device manufacturer.
Medtronic’s fiscal second-quarter net income fell 35 percent as legal and other costs outpaced weak gains in medical device sales, but adjusted results met Wall Street expectations.
Millions of people with mild or moderate heart failure got good news Sunday, with studies showing a Pfizer drug and a device from Medtronic can boost survival and cut trips to the hospital by patients having trouble breathing.
Medtronic said Thursday it has agreed to pay $268 million to settle U.S. lawsuits and claims related to its Sprint Fidelis family of defibrillation leads which it recalled three years ago.